Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Smoking Cessation 2Neoplasms 2Lung Neoplasms 2Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplasm Metastasis 1Motor Activity 1Lymphoma 1Leukemia 1Inflammation 1Colorectal Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Bevacizumab 30pembrolizumab 29Oxaliplatin 28Leucovorin 25Fluorouracil 24Irinotecan 22Cetuximab 22Capecitabine 19Nivolumab 15Specimen Handling 12atezolizumab 11Panitumumab 11Colonoscopy 9Carboplatin 9regorafenib 8Biopsy 8trifluridine tipiracil drug combination 7Trifluridine 7Paclitaxel 7Aspirin 7balstilimab 6Standard of Care 6Cisplatin 6tislelizumab 5encorafenib 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Immunoglobulin G 5Folfox protocol 5Disulfides 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Colorectal Neoplasms × Hematologic Tests × Clear all
NCT06929481 2026-05-28

Screening With a DNA Blood Test to Address Colorectal Cancer Inequities

University of California, San Diego

Phase NA Active not recruiting
340 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡